Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus etomidate + propofol for sedation in elderly patients undergoing gastroenteroscopy
ChiCTR2400084220Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ciprofol, etomidate, propofol and remifentanil in None, sponsored by Peking University People's Hospital. Primary endpoint: Success rate of gastroscopy. Planned start May 2024; status: not yet recruiting.
02
Drugs
ciprofoletomidatepropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2400084220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084220.